This move is archived. Current quotes and coverage live on the stock page.
Follow TELY
TelyRx Holdings Inc. is making waves on the TSX with a notable surge in its stock price.
TelyRx Holdings Inc. (TELY.TO) is experiencing a significant rise, with its stock climbing by 5.88% to CA$2.70 in today’s trading session. This upward momentum reflects growing investor confidence and interest in the company’s recent financial performance.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$69.14M
52W high
$4.25
52W low
$2.00
1W change
+0.00%
Analyst Price Targets
Based on analyst covering TELY · as of Sep 17, 2026
Wall Street analysts forecast TELY stock price to rise 135.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+135.3% Upside
Current Price
C$2.55
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
60.0%
Annualized
90-Day Vol
88.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.13
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.40 | C$1.95 – C$2.96 |
| 60 trading days | C$2.26 | C$1.69 – C$3.03 |
| 90 trading days | C$2.13 | C$1.49 – C$3.05 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the implications of TelyRx's recent revenue growth and market activity as potential indicators of future performance.
TelyRx Holdings Inc. Stock Up 5.88% Today
The stock's rise to CA$2.70 reflects a growing market cap of CA$71.76 million, indicating increased investor interest.
Bull case
The company recently reported a significant increase in revenue, jumping to $19.4 million from $14.3 million in the previous quarter. This growth could point to a positive trend for future earnings and heightened investor interest.
Bear case
Despite the stock's upward movement, TelyRx still faces challenges. The latest financial results show a net loss, which raises concerns about its profitability moving forward.
Advertisement
Recent Financial Performance
TelyRx recently reported its first quarter 2026 financial results, showcasing a revenue increase to $19.4 million, up from $14.3 million in the previous quarter. This growth could be a driving factor behind the stock's rise as investors react positively to the company’s improving financial health. For more details, check the full report on TelyRx's financial results.
Market Reaction
The stock's performance today reflects a broader trend of increased investor interest in TelyRx Holdings Inc. Following the completion of its qualifying transaction and subsequent trading on the TSX, the company has been in the spotlight. Investors are likely weighing the implications of its recent performance and future potential. For further insights, visit the TelyRx stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
